RU2006126532A - Бронхорелаксирующие соединения - Google Patents
Бронхорелаксирующие соединения Download PDFInfo
- Publication number
- RU2006126532A RU2006126532A RU2006126532/04A RU2006126532A RU2006126532A RU 2006126532 A RU2006126532 A RU 2006126532A RU 2006126532/04 A RU2006126532/04 A RU 2006126532/04A RU 2006126532 A RU2006126532 A RU 2006126532A RU 2006126532 A RU2006126532 A RU 2006126532A
- Authority
- RU
- Russia
- Prior art keywords
- compound according
- compound
- alkyl
- methoxy
- hydroxy
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims 51
- 230000003523 bronchorelaxing effect Effects 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 12
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 11
- 229910052736 halogen Inorganic materials 0.000 claims 10
- 150000002367 halogens Chemical class 0.000 claims 10
- 239000000460 chlorine Substances 0.000 claims 9
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 9
- -1 2- (4-chlorophenyl) ethyl Chemical group 0.000 claims 8
- 125000003118 aryl group Chemical group 0.000 claims 8
- 229910052799 carbon Inorganic materials 0.000 claims 8
- 229910052801 chlorine Inorganic materials 0.000 claims 8
- 206010006482 Bronchospasm Diseases 0.000 claims 7
- 230000007885 bronchoconstriction Effects 0.000 claims 7
- 125000001072 heteroaryl group Chemical group 0.000 claims 7
- 229910052794 bromium Inorganic materials 0.000 claims 6
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 5
- 229910052731 fluorine Inorganic materials 0.000 claims 5
- 238000000034 method Methods 0.000 claims 5
- 125000001424 substituent group Chemical group 0.000 claims 5
- 125000000217 alkyl group Chemical group 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 3
- 206010006448 Bronchiolitis Diseases 0.000 claims 3
- 206010006458 Bronchitis chronic Diseases 0.000 claims 3
- 229940127291 Calcium channel antagonist Drugs 0.000 claims 3
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 3
- 201000003883 Cystic fibrosis Diseases 0.000 claims 3
- 206010014561 Emphysema Diseases 0.000 claims 3
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 claims 3
- 239000002253 acid Substances 0.000 claims 3
- 239000000556 agonist Substances 0.000 claims 3
- 239000000924 antiasthmatic agent Substances 0.000 claims 3
- 208000006673 asthma Diseases 0.000 claims 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 3
- 201000009267 bronchiectasis Diseases 0.000 claims 3
- 206010006451 bronchitis Diseases 0.000 claims 3
- 206010006475 bronchopulmonary dysplasia Diseases 0.000 claims 3
- 239000000480 calcium channel blocker Substances 0.000 claims 3
- 239000000812 cholinergic antagonist Substances 0.000 claims 3
- 208000007451 chronic bronchitis Diseases 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 229940086198 Corticosteroid antagonist Drugs 0.000 claims 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims 2
- 239000003836 corticosteroid antagonist Substances 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N pyrocatechyl group Chemical group C=1(O)C(O)=CC=CC1 YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 claims 2
- 230000002040 relaxant effect Effects 0.000 claims 2
- 208000023504 respiratory system disease Diseases 0.000 claims 2
- 125000003107 substituted aryl group Chemical group 0.000 claims 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 2
- RGICCULPCWNRAB-UHFFFAOYSA-N 2-[2-(2-hexoxyethoxy)ethoxy]ethanol Chemical group CCCCCCOCCOCCOCCO RGICCULPCWNRAB-UHFFFAOYSA-N 0.000 claims 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 claims 1
- 208000019693 Lung disease Diseases 0.000 claims 1
- 125000003282 alkyl amino group Chemical group 0.000 claims 1
- 125000001246 bromo group Chemical group Br* 0.000 claims 1
- 239000003246 corticosteroid Substances 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 125000004663 dialkyl amino group Chemical group 0.000 claims 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- HJXZSICYCQHWLW-UHFFFAOYSA-N Oc(c(Cl)c(CCN(C1)C(NCc(cc2)ccc2Cl)=S)c1c1Cl)c1O Chemical compound Oc(c(Cl)c(CCN(C1)C(NCc(cc2)ccc2Cl)=S)c1c1Cl)c1O HJXZSICYCQHWLW-UHFFFAOYSA-N 0.000 description 1
- GPEVEXJTBVDKQO-UHFFFAOYSA-N Oc(c(O)c(c(C1)c2CCN1C(NCCc1ccncc1)=S)Cl)c2Cl Chemical compound Oc(c(O)c(c(C1)c2CCN1C(NCCc1ccncc1)=S)Cl)c2Cl GPEVEXJTBVDKQO-UHFFFAOYSA-N 0.000 description 1
- XNAGSTQTVAKMJR-UHFFFAOYSA-N Oc(cc(CCN(CC1)C(NCCc(cc2)ccc2Cl)=S)c1c1Cl)c1O Chemical compound Oc(cc(CCN(CC1)C(NCCc(cc2)ccc2Cl)=S)c1c1Cl)c1O XNAGSTQTVAKMJR-UHFFFAOYSA-N 0.000 description 1
- BOACHVFKSHBFBT-UHFFFAOYSA-N Oc(cc(CN(CC1)C(NCCc(cc2)ccc2Cl)=S)c1c1Cl)c1O Chemical compound Oc(cc(CN(CC1)C(NCCc(cc2)ccc2Cl)=S)c1c1Cl)c1O BOACHVFKSHBFBT-UHFFFAOYSA-N 0.000 description 1
- RHZNSWYMJOWUEH-UHFFFAOYSA-N Oc1c(CN(C2)C(NCCc(cc3)ccc3Cl)=S)c2ccc1 Chemical compound Oc1c(CN(C2)C(NCCc(cc3)ccc3Cl)=S)c2ccc1 RHZNSWYMJOWUEH-UHFFFAOYSA-N 0.000 description 1
- XIAGXFJITHPNQZ-UHFFFAOYSA-N Oc1ccc(CCCN(C2)C(NCCc(cc3)ccc3Cl)=S)c2c1 Chemical compound Oc1ccc(CCCN(C2)C(NCCc(cc3)ccc3Cl)=S)c2c1 XIAGXFJITHPNQZ-UHFFFAOYSA-N 0.000 description 1
- LUNOQCSVISQVIM-UHFFFAOYSA-N Oc1ccc(CN(CC2)C(NCCc(cc3)ccc3Cl)=S)c2c1 Chemical compound Oc1ccc(CN(CC2)C(NCCc(cc3)ccc3Cl)=S)c2c1 LUNOQCSVISQVIM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/761,323 US20050165004A1 (en) | 2004-01-22 | 2004-01-22 | Bronchorelaxing compounds |
| US10/761,323 | 2004-01-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2006126532A true RU2006126532A (ru) | 2008-02-27 |
Family
ID=34794812
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2006126532/04A RU2006126532A (ru) | 2004-01-22 | 2005-01-21 | Бронхорелаксирующие соединения |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20050165004A1 (https=) |
| EP (1) | EP1708999A1 (https=) |
| JP (1) | JP2007518798A (https=) |
| CN (1) | CN1910149A (https=) |
| RU (1) | RU2006126532A (https=) |
| WO (1) | WO2005070887A1 (https=) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2406435C1 (ru) * | 2009-09-10 | 2010-12-20 | Государственное образовательное учреждение высшего профессионального образования "Воронежская государственная медицинская академия им. Н.Н. Бурденко Федерального агентства по здравоохранению и социальному развитию" | Фармакологическая коррекция повышенного симпатического тонуса при назначении антагонистов кальция у больных с сочетанием артериальной гипертензии и бронхиальной астмы |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007011290A1 (en) * | 2005-07-18 | 2007-01-25 | Respiratorius Ab | Bronchorelaxing agents based on indol- and isoquinoline derivatives |
| US20070293475A1 (en) * | 2006-06-20 | 2007-12-20 | Alcon Manufacturing Ltd. | Aryl and heteroaryl tetrahydrobenzazepine derivatives and their use for treating glaucoma |
| WO2009007419A1 (en) * | 2007-07-12 | 2009-01-15 | Respiratorius Ab | Novel bronchodilating isoquinoline carbamates |
| WO2009007418A1 (en) * | 2007-07-12 | 2009-01-15 | Respiratorius Ab | Novel bronchodilating isoquinoline amides |
| SE531698C2 (sv) * | 2007-07-12 | 2009-07-07 | Respiratorius Ab | Nya bronkdilaterande a,b-omättade amider |
| US20090318413A1 (en) * | 2008-06-18 | 2009-12-24 | Universite Victor Segalen Bordeaux 2 | Bronchial smooth muscle remodeling involves calcium-dependent enhanced mitochondrial biogenesis in asthma |
| WO2016033105A1 (en) * | 2014-08-29 | 2016-03-03 | The Board Of Regents Of The University Of Texas System | Novel capsazepine analogs for the treatment of cancer and other proliferative diseases |
| CN107298655B (zh) * | 2017-08-24 | 2019-11-15 | 郑州轻工业学院 | 7,8-二甲氧基-2,3,4,5-四氢-1H-苯并[c]氮杂卓盐酸盐及其制备方法 |
| KR20210032315A (ko) * | 2018-07-06 | 2021-03-24 | 레스피라토리우스 아브 | 신규한 기관지 확장형 헤테로 결합된 아미드 |
| KR102590643B1 (ko) * | 2019-01-31 | 2023-10-17 | 히사미쓰 세이야꾸 가부시키가이샤 | 첩부제 |
| WO2023028257A1 (en) * | 2021-08-27 | 2023-03-02 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Compositions and methods for treating neurodegenerative disorders |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1029326A (en) * | 1964-03-18 | 1966-05-11 | Dresden Arzneimittel | Isoindoline-2-carboxylic acid amides |
| DE2620179A1 (de) * | 1975-10-28 | 1977-05-12 | Knoll Ag | Neue isochinolin-derivate |
| US4963563A (en) * | 1989-10-13 | 1990-10-16 | Abbott Laboratories | 6-substituted-1,2,3,4-tetrahydroisoquinolines |
| ATE328868T1 (de) * | 2000-08-21 | 2006-06-15 | Pacific Corp | Neue (thio)harnstoffverbindungen und arzneimittelkompositionen, die diese enthalten |
| AU2001280229B2 (en) * | 2000-08-21 | 2006-12-07 | Pacific Corporation | Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| AU2002235277A1 (en) * | 2000-10-23 | 2002-05-06 | Smith Kline Beecham Corporation | Compounds and methods |
| ES2193839B1 (es) * | 2001-06-22 | 2005-02-16 | Almirall Prodesfarma, S.A. | Nuevos derivados de 6-fenildihidropirrolpirimidindiona. |
| JP2003192660A (ja) * | 2001-12-26 | 2003-07-09 | Bayer Ag | 尿素誘導体 |
| EP1489071A1 (en) * | 2003-06-18 | 2004-12-22 | 4Sc Ag | N-substituted, 3,4-dihydro-1H-isoquinoline as potassium channels modulators |
| EP1660454A1 (en) * | 2003-07-07 | 2006-05-31 | Vernalis (R&D) Limited | Azacyclic compounds as inhibitors of sensory neurone specific channels |
-
2004
- 2004-01-22 US US10/761,323 patent/US20050165004A1/en not_active Abandoned
-
2005
- 2005-01-21 EP EP05704735A patent/EP1708999A1/en not_active Withdrawn
- 2005-01-21 WO PCT/SE2005/000062 patent/WO2005070887A1/en not_active Ceased
- 2005-01-21 JP JP2006550993A patent/JP2007518798A/ja active Pending
- 2005-01-21 RU RU2006126532/04A patent/RU2006126532A/ru not_active Application Discontinuation
- 2005-01-21 CN CNA2005800025671A patent/CN1910149A/zh active Pending
- 2005-07-22 US US11/186,841 patent/US20060040919A1/en not_active Abandoned
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2406435C1 (ru) * | 2009-09-10 | 2010-12-20 | Государственное образовательное учреждение высшего профессионального образования "Воронежская государственная медицинская академия им. Н.Н. Бурденко Федерального агентства по здравоохранению и социальному развитию" | Фармакологическая коррекция повышенного симпатического тонуса при назначении антагонистов кальция у больных с сочетанием артериальной гипертензии и бронхиальной астмы |
Also Published As
| Publication number | Publication date |
|---|---|
| US20050165004A1 (en) | 2005-07-28 |
| CN1910149A (zh) | 2007-02-07 |
| US20060040919A1 (en) | 2006-02-23 |
| WO2005070887A1 (en) | 2005-08-04 |
| EP1708999A1 (en) | 2006-10-11 |
| JP2007518798A (ja) | 2007-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2642216T3 (es) | Compuestos de hidroxilo y composiciones para el control del colesterol y utilizaciones correspondientes | |
| AU2015214096B2 (en) | Combination therapy for treatment of HBV infections | |
| RU2477723C2 (ru) | Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе | |
| RU2006126532A (ru) | Бронхорелаксирующие соединения | |
| ES2356093T3 (es) | Combinación farmacéutica que comprende 3-(3-dimetilamino-1-etil-2-metilpropil)fenol y paracetamol. | |
| CN101299920A (zh) | 用选择性雄激素受体调节剂治疗肾病、烧伤、创伤和脊髓损伤 | |
| RU2005123802A (ru) | Производные адамантана, способы их получения и содержащие их фармацевтические композиции | |
| JP2010514696A (ja) | 心血管症状の低減 | |
| RU98118568A (ru) | Триарильные соединения | |
| JP2004514663A5 (https=) | ||
| RU2009123525A (ru) | ПРОИЗВОДНЫЕ 5-СУЛЬФАНИЛМЕТИЛ[1,2,4}ТРИАЗОЛ[1,5-а]ПИРИМИДИН-7-ОЛА В КАЧЕСТВЕ АНТАГОНИСТОВ CXCR2 | |
| TWI669113B (zh) | 用於治療癌症之氧烯洛爾（ｏｘｐｒｅｎｏｌｏｌ）組合物 | |
| CA3037146A1 (en) | Method of reducing thyroid-associated side effects | |
| JP2018525430A5 (https=) | ||
| RU2002101622A (ru) | Нафтохиноновые производные и их использование для лечения и борьбы с туберкулезом | |
| JP2007518798A5 (https=) | ||
| RU2019128534A (ru) | Химические соединения для лечения туберкулеза | |
| JP2007525533A5 (https=) | ||
| RU2008108175A (ru) | Комбинация соединений, которые можно использовать при лечении респираторных заболеваний, особенно хронической оструктивной болезни легких (copo) и астмы | |
| RU2007105582A (ru) | Агонисты рецепторов никотина и способы их применения для лечения воспалительных заболеваний | |
| BRPI0718199A2 (pt) | Composição, e, métodos para estabilizar o ritmo da respiração de um mamífero, e para aumentar a ventilação por minuto no nível dos centros de controle respiratório do tronco cerebral no nucleus tractus solitarius de um indivíduo. | |
| KR102840064B1 (ko) | 폐섬유화증의 예방 또는 치료용 약학 제제 | |
| US20050192243A1 (en) | Neuromuscular blocking agents and antagonists thereof | |
| JP2005529110A5 (https=) | ||
| RU2004109817A (ru) | Производные аминопиррола в качестве противовоспалительных средств |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20090330 |